Shiferman Gregory L. 4
4 · Sage Therapeutics, Inc. · Filed Feb 14, 2025
Insider Transaction Report
Form 4
Shiferman Gregory L.
See Remarks
Transactions
- Tax Payment
Common Stock
2025-02-13$7.18/sh−251$1,802→ 33,261 total - Tax Payment
Common Stock
2025-02-13$7.18/sh−376$2,700→ 33,512 total
Footnotes (2)
- [F1]On February 13, 2025, the reporting person vested 1,125 shares of time-based restricted stock units (RSUs) granted on February 13, 2023 under the Sage Therapeutics, Inc. 2014 Stock Option and Incentive Plan. This grant vests 25% on each grant anniversary date over four years. Represents shares withheld to satisfy tax withholding obligations on the vesting of restricted stock units.
- [F2]On February 13, 2025, the reporting person vested 750 shares of time-based restricted stock units (RSUs) granted on February 13, 2024 under the Sage Therapeutics, Inc. 2014 Stock Option and Incentive Plan. This grant vests 25% on each grant anniversary date over four years. Represents shares withheld to satisfy tax withholding obligations on the vesting of restricted stock units.